Compound Detail
CHEMBL1131
ACITRETIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1131 |
| Name | ACITRETIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IHUNBGSDBOWDMA-AQFIFDHZSA-N |
| Therapeutic | ✓ Yes |
5
Targets
8
Activities
2
Assay Types
1
PK Parameters
20
Publications
11
Known Names
6
Indications
1
Mechanisms
Molecular Properties
326.4
MW (Da)
5.17
ALogP
2
HBA
1
HBD
46.5
PSA (Ų)
0.58
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1996 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Retinoid receptor agonist | AGONIST | Retinoid receptor | ✓ | ✓ |
Indications
Psoriasis Psoriasis Alzheimer Disease Dermatitis Melanoma HIV Infections
ATC Classification
D05BB02
acitretin
Level 1: DERMATOLOGICALS
Level 2: ANTIPSORIATICS
Drug Warnings
Black Box Warning
teratogenicity
Black Box Warning
hepatotoxicity
Activity Summary
IC50 7 meas. best 5.81
Ki 1 meas. best 5.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 5.81 | 5.21 | 1560.0 | 2 |
| Unchecked CHEMBL612545 | Ki | 5.1 | 5.1 | 8000.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 4.84 | 4.84 | 14600.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.74 | 4.58 | 18200.0 | 2 |
| Bile salt export pump CHEMBL2073674 | IC50 | 4.71 | 4.71 | 19700.0 | 1 |
| ATP-binding cassette sub-family C member 4 CHEMBL1743128 | IC50 | 4.31 | 4.31 | 49000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2000.1 | ng.hr.mL-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine